We are live on ! Find out more
HAE icon

Haemonetics

324 hedge funds and large institutions have $2.68B invested in Haemonetics in 2026 Q1 according to their latest regulatory filings, with 57 funds opening new positions, 117 increasing their positions, 110 reducing their positions, and 55 closing their positions.

New
Increased
Maintained
Reduced
Closed

166% more call options, than puts

Call options by funds: $6.75M | Put options by funds: $2.54M

6% more repeat investments, than reductions

Existing positions increased: 117 | Existing positions reduced: 110

4% more first-time investments, than exits

New positions opened: 57 | Existing positions closed: 55

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

1% less funds holding

Funds holding: 328324 (-4)

6.15% less ownership

Funds ownership: 108.62%102.48% (-6.1%)

34% less capital invested

Capital invested by funds: $4.07B → $2.68B (-$1.39B)

Holders
324
Holders Change
-4
Holders Change %
-1.22%
% of All Funds
3.99%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
57
Increased
117
Reduced
110
Closed
55
Calls
$6.75M
Puts
$2.54M
Net Calls
+$4.21M
Net Calls Change
-$59M
Name Holding Trade Value Shares
Change
Change in
Stake
HI
126
Horizon Investments
North Carolina
$1.29M -$460K -7,069 -24%
Jennison Associates
127
Jennison Associates
New York
$1.27M +$679K +10,433 +86%
MHC
128
May Hill Capital
Massachusetts
$1.26M
Mirae Asset Global ETFs Holdings
129
Mirae Asset Global ETFs Holdings
Hong Kong
$1.24M -$22.3K -343 -2%
ZBNA
130
Zions Bancorporation, National Association
Utah
$1.23M -$1.05M -16,062 -42%
AIC
131
Aurora Investment Counsel
Georgia
$1.22M +$1.41M +21,595 New
MP
132
Mangrove Partners
Connecticut
$1.2M +$1.19M +18,345 +606%
PAM
133
Panagora Asset Management
Massachusetts
$1.2M +$1.39M +21,362 New
IC
134
IEQ Capital
California
$1.18M -$607K -9,326 -31%
CL
135
CSS LLC
Illinois
$1.17M +$1.35M +20,721 New
CIM
136
Confluence Investment Management
Missouri
$1.16M -$525K -8,063 -28%
HighTower Advisors
137
HighTower Advisors
Illinois
$1.14M +$172K +2,640 +15%
AB
138
Amalgamated Bank
New York
$1.14M +$25.4K +390 +2%
SDIC
139
South Dakota Investment Council
South Dakota
$1.11M
State of Tennessee, Department of Treasury
140
State of Tennessee, Department of Treasury
Tennessee
$1.07M
VGA
141
Vanguard Global Advisers
Pennsylvania
$1.05M +$1.21M +18,641 New
BHCM
142
Brevan Howard Capital Management
Jersey
$1.04M +$212K +3,251 +21%
Zurich Cantonal Bank
143
Zurich Cantonal Bank
Switzerland
$1.03M +$1.19M +18,339 New
TI
144
Tidal Investments
Wisconsin
$1.01M +$228K +3,501 +24%
Creative Planning
145
Creative Planning
Kansas
$1M -$589K -9,047 -34%
MOACM
146
Mutual of America Capital Management
New York
$1M -$109K -1,673 -9%
Victory Capital Management
147
Victory Capital Management
Texas
$990K +$50.6K +777 +5%
Canada Pension Plan Investment Board
148
Canada Pension Plan Investment Board
Ontario, Canada
$981K +$723K +11,100 +176%
TRSOTSOK
149
Teachers Retirement System of the State of Kentucky
Kentucky
$951K
WB
150
WesBanco Bank
West Virginia
$907K +$1.05M +16,100 New

HAE Hedge Fund Activity: Q1 2026 in Review

324 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Haemonetics (HAE) for Q1 2026, worth a combined $2.68B — down 34% from $4.07B a quarter earlier.

Buyers outnumbered sellers: 57 funds opened new HAE positions and 55 closed out — a net gain of 2 holders — while 117 added to existing stakes and 110 trimmed.

The largest buyer was Invenomic Capital Management, opening a new position worth an estimated $43.3M. The largest seller was Holocene Advisors, cutting an estimated $82M.

  • 324 institutional investors held Haemonetics (HAE) as of Q1 2026, down from 328 in Q4 2025.
  • Funds reported $2.68B of Haemonetics stock for Q1 2026, down 34% quarter-over-quarter.
  • 57 funds opened new Haemonetics positions in Q1 2026 and 55 closed out, a net change of +2 holders.
  • The largest Haemonetics buyer in Q1 2026 was Invenomic Capital Management, an estimated $43.3M added.
  • The largest Haemonetics seller in Q1 2026 was Holocene Advisors, an estimated $82M sold.

Based on aggregated 13F filings for Q1 2026.